
|Articles|November 1, 2002
Hyperopia clinical module submitted to FDA
Fremont, CA-Nidek Inc. has submitted its hyperopia PMA clinical module to the FDA for review and approval of its EC-5000 Excimer Laser System for hyperopia, hyperopic astigmatism, and mixed astigmatism. This marks the final step in gaining commercialization approval by the FDA to market and treat indications of hyperopia with the Nidek system.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Sandoz Canada launches aflibercept biosimilar, Enzeevum
2
AMD and low vision awareness month: Using the MTII to evaluate progression of GA
3
Noninvasive LED light therapy shows long-term safety in early cataract clinical follow-up
4
EnVision Summit 2026: Ultimate gathering place for ophthalmic education
5




























